GENE ONLINE|News &
Opinion
Blog

2020-01-30| COVID-19

Update On 2019 Novel Coronavirus (2019-nCov): The Latest Progress In Vaccine Development And Treatment

by Sherry
Share To

Efforts Around the World to Develop Vaccines

Anthony Fauci, director of the US National Institute of Alliance and Infectious Diseases (NIAID), claims that they are confident to conduct a clinical phase I trial of a vaccine against the 2019-nCov in three months or less.

Johnson & Johnson has begun research on the virus and has applied its technology platform for rapid and large-scale production of optimized vaccine candidates. Meanwhile, Moderna and Inovio Pharma have announced plans to work together to develop a vaccine.

The Chinese and Russian governments are also attempting to co-develop a vaccine, and Beijing has transferred the 2019-nCoV genome data to Moscow. “Russian and Chinese experts have started developing vaccines against coronavirus,” the Russian Consulate in Guangzhou said in a statement.

Despite these accelerated developments, Novartis CEO Vas Narasimhan has shared a different view. He warned that it would take at least a year to develop an effective vaccine, and what is needed now is epidemiological control to reduce the outbreak.

Antiviral Drug

Gilead Sciences is evaluating whether its experimental RNA polymerase inhibitor remdesivir, originally developed for the treatment of Ebola, can be used against the coronavirus. Besides, AbbVie stated that it had donated USD 2 million worth HIV drug Kaletra (lopinavir / ritonavir) as an “experimental option” at the request of Chinese health authorities.

Cell Therapy

Cell therapy-related companies are not shying away from this fight either. Sorrento Therapeutics has announced a collaboration with Celularity for clinical development and manufacturing. The goal is to extend the therapeutic use of Celularity’s CYNK-001 (an allogeneic, off-the-shelf, placental-derived Natural Killer cell therapy) to treat and prevent coronavirus infections.

Related Article: Understanding the Scientific Challenges in Combating the New Coronavirus


References
  1. https://www.marketwatch.com/story/coronavirus-update-vaccine-expected-in-phase-1-trial-within-months-who-to-reconvene-on-thursday-2020-01-29
  2. https://www.jnj.com/latest-news/what-you-need-to-know-about-coronavirus-and-a-potential-johnson-johnson-vaccine
  3. https://www.nytimes.com/2020/01/28/health/coronavirus-vaccine.html
  4. https://www.washingtonpost.com/world/asia_pacific/coronavirus-china-live-updates/2020/01/29/d49b9194-423b-11ea-b503-2b077c436617_story.html
  5. https://www.sciencemag.org/news/2020/01/can-anti-hiv-combination-or-other-existing-drugs-outwit-new-coronavirus
  6. https://www.covaxx.com/press-release-jul15-1

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Connecting the Dots: TCELS Leads the Way for Thailand’s Life Sciences and Healthcare Innovations
2023-09-20
GeneOnline’s Weekly News Highlights: Sept 11-Sept 15
2023-09-19
Novartis’ Generic-drugs Unit Partners with Samsung Bioepis for Biosimilar Drug Launch
2023-09-12
LATEST
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
Partnership to Manufacture Antibiotic to Combat Antimicrobial Resistance
2023-09-25
Revolutionary Technology Aims to Detect and Prevent Dementia and Mental Illness
2023-09-22
Connecting Global Biotech, Largest Biotech Event of Thailand Takes Center Stage
2023-09-22
BIOHK2023: A Place Where Biotechnology Meets Financial Economics
2023-09-21
Connecting the Dots: TCELS Leads the Way for Thailand’s Life Sciences and Healthcare Innovations
2023-09-20
Deceptive Health Advice on TikTok Raises Concerns About Gynecologic Cancer Misinformation
2023-09-20
EVENT
2023-10-04
BioFuture 2023
New York city,USA
Scroll to Top